Aurobindo Pharma reported INR327.09B in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Cipla INR 250.61B 9.14B Sep/2026
Divis Laboratories Ltd INR 110.96B 12.53B Mar/2026
Dr.Reddys Laboratories INR 297.32B 2.01B Sep/2026
Hindustan Unilever INR 221.34B 31.13B Sep/2026
Sun Pharmaceuticals INR 638.6B 37.24B Mar/2026
UPL INR 422.95B 9.97B Mar/2026